A significant shift in Canadian drug policy has occurred, as the regulators allow the availability of psilocybin mushrooms for therapeutic applications. Before this, these substances were heavily restricted, but a increasing body of research suggests they potentially offer aid for psychological issues like PTSD. This change represents a key step to